FADE HQ

Texto original en francés.

Producto de salud natural autorizado en Canadá

Titular

RGR Pharma Ltd.

NPN o DIN-HM

80048450

Estado

Licencia no activa

Fecha de licencia

18 de febrero de 2014

Fecha de revisión

No indicada

Forma

Crème

Vía de administración

Topique

Tipo de solicitud

Non traditionnelle

Composición

Composición medicinal no indicada.

Ingredientes no medicinales

BHT, Béhénate de béhényle, Eau purifiée, Stéarate de glycéryle, Sorbate de potassium, Lévulinate de sodium, EDTA de sodium, Acide ascorbique, Quillaja extract, Acide DL-lactique, Métabisulfite de sodium, Alcool cétylique, Stéarate de PEG-100, Glycérine, d-alpha tocophérol (Vitamine E)

Dosis recomendadas en Canadá

Usos autorizados en Canadá

For the gradual lightening of hyperpigmented skin conditions.

Texto original en inglés.

Un uso autorizado en Canadá no es una declaración de propiedades saludables autorizada en la Unión Europea. Consulte el registro de declaraciones de propiedades saludables.

Advertencias en Canadá

Cautions and Warnings : If you have a family history of, have or have had, or are at risk of developing cancer, do not use. To be used only on the advice of a physician. Do not use this product if you are nursing, pregnant, or intend to become pregnant within three months of use. For external use only. Do not use on mucous membranes, or on broken or irritated skin. In case of contact, rinse thoroughly with water. Apply only to small skin surface areas. Discontinue use and consult a physician in case of skin reaction or a blue-black darkening of the skin. In case of accidental ingestion, seek medical assistance or contact a Poison Control Center immediately. Not for use on children under 12 years of age. Keep out of reach of children. Use only as directed. Do not apply over sunburn or irritated skin. A mild transient stinging or minor redness may occur in people with sensitive skin. To test for sensitivity apply to an area of approximately 1 to 2 cm of unbroken skin on the inside of the arm. If no irritation occurs within 24 hours, begin treatment for up to 12 weeks. Discontinue use in case of irritation, rash, excessive inflammatory response of if a gradual blue-black darkening of the skin (exogenous ochronosis) occurs. Minor redness is acceptable, but where there is excessive irritation, a rash or other reaction, further treatment is not advised. Severe itching or reddening may occur, in which case the product should be discontinued and the physician notified immediately. Note slight darkening of the product is normal and does not affect its potency. The physician should be familiar with the contents of this insert before prescribing or dispensing this product. Hydroquinone is a skin bleaching agent which may produce unwanted cosmetic effects if not used as directed. Avoid contact with eyes. In case of accidental contact patient should rinse eyes thoroughly with water and contact a physician. A bitter taste and anesthetic effect may occur if applied to lips. Sunscreen use is an essential aspect of Hydroquinone therapy because even minimal sunlight exposure sustains melanocytic activity. Test for skin sensitivity before using by applying a small amount to an unbroken patch of skin and check in 24 hours. Minor redness is not a contraindication but when there is itching or vesicle formation or excessive inflammation response, further treatment is not advised. Close patient supervision is recommended. Treatment should be limited to small areas of the body.

Texto original en inglés.

Fuente

Ficha oficial de Health Canada, licencia 80048450

Base de datos de productos de salud natural autorizados (BDPSNH), Health Canada: productos autorizados, ingredientes, dosis, usos y advertencias, consultado el 27 de octubre de 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Texto original en inglés.

La fórmula vendida en Europa con el mismo nombre puede ser diferente. Esta información no sustituye el consejo de un médico o farmacéutico.

Se desconoce la fecha de la prueba de esta lista de ingredientes.

¿Ha cambiado el producto? Fotografíe el envase.

¿Alguna información inexacta o más reciente sobre este producto, sea usted lector o marca? Escriba a contact@compoatlas.com: cada corrección se publica en el registro de correcciones.